Fact Meets Function

Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer’s disease pathology in APP/PS1 mice.

This study tested NMN supplementation in mice with Alzheimer’s disease and found it improved both gut health and brain function. NMN restored healthy gut bacteria balance, reduced brain inflammation, and enhanced memory performance in the test animals. The research suggests NMN works through a gut-brain connection, improving the intestinal barrier while also protecting brain cells from damage. These findings indicate NMN may offer a dual approach to supporting both digestive and cognitive health.

Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer’s disease pathology in APP/PS1 mice. Read Post »

Glycyl-L-histidyl-L-lysine-Cu2+ (GHK-Cu) Attenuates CuSO4 or LPS induced-Inflammation in Zebrafish larvae model.

A new zebrafish study demonstrates GHK-Cu’s anti-inflammatory effects, showing it reduces immune cell migration, suppresses pro-inflammatory cytokines, and increases anti-inflammatory markers while reducing oxidative stress. This research provides important mechanistic evidence for GHK-Cu’s therapeutic benefits beyond its known anti-aging properties. The study validates the compound’s dual anti-inflammatory and antioxidant capabilities, supporting its use in conditions involving chronic inflammation.

Glycyl-L-histidyl-L-lysine-Cu2+ (GHK-Cu) Attenuates CuSO4 or LPS induced-Inflammation in Zebrafish larvae model. Read Post »

Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration.

This animal study tested a combination of NMN (which boosts NAD+ levels) and apigenin (which prevents NAD+ breakdown) in aging mice. The combination helped preserve muscle mass, bone density, and cartilage health while improving exercise capacity. The treatment worked by maintaining cellular energy levels and supporting healthy gut bacteria that produce beneficial metabolites.

Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration. Read Post »

Nicotinamide mononucleotide attenuates hepatic endoplasmic reticulum stress and modulates circadian rhythms in young mice with diet-induced obesity.

This study tested whether NMN supplementation could help young mice avoid metabolic problems when eating a high-fat diet. The researchers found that NMN reduced liver stress and helped regulate the body’s internal clock, even in younger animals. This suggests NMN may help prevent metabolic dysfunction before it becomes severe, not just treat existing age-related decline.

Nicotinamide mononucleotide attenuates hepatic endoplasmic reticulum stress and modulates circadian rhythms in young mice with diet-induced obesity. Read Post »

Unraveling the therapeutic potential of neochlorogenic acid Cu-supramolecular complexes in acute lung injury: Targeting PI3K/NF-κB/iNOS pathway through spatial metabolomics-guided.

This study investigated a copper complex (similar to GHK-Cu) for treating severe lung injury and respiratory distress. Researchers found the copper compound helped reduce lung inflammation by targeting specific cellular pathways. The treatment showed promise for protecting lung tissue during acute respiratory conditions.

Unraveling the therapeutic potential of neochlorogenic acid Cu-supramolecular complexes in acute lung injury: Targeting PI3K/NF-κB/iNOS pathway through spatial metabolomics-guided. Read Post »

Sirt1-eIF2α axis drives pro-inflammatory macrophage activation through ER stress aggravating liver IRI in aged mice.

This study found that older livers are more prone to damage after transplant surgery due to increased inflammation from immune cells called macrophages. When researchers gave NMN supplements to aged mice, it restored cellular energy levels and reduced this harmful inflammation in the liver. The NMN worked by activating a protein called Sirt1 that helps control inflammatory responses. This suggests NMN could help protect older organs during surgical procedures.

Sirt1-eIF2α axis drives pro-inflammatory macrophage activation through ER stress aggravating liver IRI in aged mice. Read Post »

Pretreatment With Methylene Blue Atenuates Seizures, Cognitive Impairment, Hippocampal Neuronal Damage and Oxidative Stress in Pentylenetetrazole-Kindled Rats.

This animal model study investigated whether pretreatment with methylene blue could reduce seizures and associated brain damage in rats subjected to repeated seizure induction via pentylenetetrazole. Researchers found that methylene blue pretreatment attenuated seizure severity, prevented cognitive impairment, reduced hippocampal neuronal damage, and decreased oxidative stress markers compared to untreated seizure-prone rats. This is an animal model study with potential translational relevance, though findings require further investigation in human clinical populations before any clinical applications can be considered.

Pretreatment With Methylene Blue Atenuates Seizures, Cognitive Impairment, Hippocampal Neuronal Damage and Oxidative Stress in Pentylenetetrazole-Kindled Rats. Read Post »

Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis.

This animal study shows GHRP-6 (similar to Annular’s Growth-1295) significantly reduced lung injury and prevented progression to pulmonary fibrosis in mice. The peptide reduced inflammation, improved lung function, and preserved tissue integrity in both acute and chronic scenarios. This is the first study demonstrating lung protective effects for this class of peptides, potentially expanding therapeutic applications beyond traditional growth hormone benefits.

Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis. Read Post »

Development of Freeze-Dried Hyaluronic Acid Sheets for Healing Oral Mucositis: Influence of Hyaluronic Acid Molecular Weight and Nicotinamide Mononucleotide Loading on Healing Efficacy.

Researchers tested different formulations of hyaluronic acid sheets loaded with NMN to treat severe mouth sores that occur during cancer treatment. They found that 800 kDa hyaluronic acid sheets provided the best healing results in animal studies. The NMN-loaded sheets stayed in place well and released the compound steadily, showing promise as a safe treatment for painful mouth ulcers in cancer patients.

Development of Freeze-Dried Hyaluronic Acid Sheets for Healing Oral Mucositis: Influence of Hyaluronic Acid Molecular Weight and Nicotinamide Mononucleotide Loading on Healing Efficacy. Read Post »

β-Nicotinamide mononucleotide preserves muscle strength in septic male mice.

This study found that sepsis patients often develop persistent muscle weakness even after recovery, which is linked to damaged cellular powerhouses (mitochondria) in muscle tissue. Researchers discovered that NMN supplementation helped preserve muscle strength in septic mice by protecting these mitochondria. The treatment worked by supporting a key protein called SIRT3 that helps maintain healthy muscle cell energy production.

β-Nicotinamide mononucleotide preserves muscle strength in septic male mice. Read Post »

Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.

This animal study demonstrates that GHRP-6 (related to Annular’s Growth-1295) significantly improved heart function and reduced tissue damage after heart attack by enhancing mitochondrial metabolism and reducing inflammation. The research provides strong preclinical evidence for cardioprotective benefits of growth hormone-releasing peptides. This supports the therapeutic potential of Annular’s Growth-1295 for cardiovascular applications in clinical practice.

Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation. Read Post »

Neutrophil-Driven Cascade-Targeted Nanocarriers Restore Mitochondrial Homeostasis to Ameliorate Renal Ischemia-Reperfusion Injury.

Researchers developed a targeted drug delivery system that uses NMN (a compound that boosts cellular energy) to treat kidney damage caused by reduced blood flow. In mouse studies, this system successfully delivered NMN directly to injured kidney cells, restored their energy production, and prevented both immediate kidney damage and long-term scarring. The treatment works by boosting NAD+ levels in kidney cells, which helps repair their cellular powerhouses (mitochondria).

Neutrophil-Driven Cascade-Targeted Nanocarriers Restore Mitochondrial Homeostasis to Ameliorate Renal Ischemia-Reperfusion Injury. Read Post »

Scroll to Top